Medical device maker Clearstream Technologies has reported a significant increase in business and is confident this pattern will continue in the year ahead.
In a trading statement released today, Clearstream said the pickup in business was based across its product range, with a notable rise in demand for its stent delivery catheters.
The growth in distributors also reflects the anticipated launch of the company's new drug eluting stent, the Intrepide.
Clearstream is confident that it can capture a share of the worldwide market for such stents which is estimated to be around $5 billion annually and is currently served by few providers. The company also confirmed it is seeking offer more products through third party distribution agreements.
At an egm held yesterday shareholders approved a share placing to raise a further €4.4 million to fund R&D.
The interim results for the six months ended January 31st, 2006, will be announced on March 30th, 2006.